COVID-19 Consumer Health Trends & What They Mean for Marketers

As the short- and long-term effects of COVID-19 impact everyday life, marketers—especially those engaged ...

My Other Life with Mark Weihmann

PM360 recently spoke to Mark Weihmann, Director, Managed Markets Marketing at Sunovion Pharmaceuticals, about ...

The Unintended Consequences Behind Gilead’s Remdesivir Pricing Announcement

At the end of June, Gilead announced its long-awaited pricing strategy for remdesivir, which ...

The Ever-Evolving Remote Patient Monitoring Reimbursement Landscape

The urgency of the COVID-19 pandemic has illustrated how essential telehealth services are to ...

Digital Transformation and COVID-19: Catalyst for Change

COVID-19 has been a wake-up call for pharma to evaluate their organization’s digital maturity ...

A Nimble Social Strategy a Must for Reopening Physician Practices

As all organizations try to adapt to doing business in the COVID environment, it ...

Despite COVID-19, The Doctor is Still In

While pharma sales rep access has been shut down, the vast majority of physician ...

COVID-19’s Long-Lasting Impact on Clinical Trials

With COVID-19 impacting the conduct of clinical trials, a lot of discussion has been ...